Funding for this research was provided by:
National Institutes of Health (U01 GM115486, U24 MH06845)
Pharmaceutical Research and Manufacturers of America Foundation (Pharmaceutical Research and Manufacturers of America Foundation)
German Ministry of Education and Research (German Ministry of Education and Research)
Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence ‘Inflammation at Interfaces’ (Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence ‘Inflammation at Interfaces’)
Text and Data Mining valid from 2019-09-30
Received: 18 February 2019
Accepted: 29 August 2019
First Online: 30 September 2019
Ethics approval and consent to participate
: The experiments were performed in accordance with the Declaration of Helsinki. Patient recruitment and exome sequencing were approved by the Ethics Committee of the University Hospital S.-H. In Kiel (ID A156/03), and all participants gave their informed consent.
: Not applicable.
: The authors declare that they have no competing interests. YA was an independent researcher at time of work reported in the manuscript. He does not have any competing interests due to his current affiliation to Elastic NV.